[20]
Zuo QZ, Kong L, Xie Y. HIV/AIDS epidemic characteristics and risk factors in China. J Jinan Univ (Natural Science & Medicine Edition) 1998; 6: 32-3.
[21]
Wang LY, Qin QQ, Ding ZW, et al. Current situation of AIDS epidemic in China. Chinese J AIDS STD 2017; 23(04): 330-3.
[35]
Bao Y, Wang XH, He TP, et al. HIV-1 molecular epidemiology and co-infection of different subtypes in Shenzhen. Infectious Disease Information 2011; 24(331): 333-8.
[38]
Chen M, Wang JB, Xing H, et al. [HIV-1 drug resistance transmission threshold survey in Dehong prefecture of Yunnan province, 2015 Zhonghua Liu Xing Bing Xue Za Zhi 2017; 38(7): 959-62.
[43]
Fang EZ. Research on molecular epidemiology of HIV-1 infection among IDUs in Yunnan Master. Kunming University of Science and Technology 2009.
[44]
Han ZG, Xing H, Xu HF, et al. Molecular epidemiological study of HIV-1 positive individuals in Guangzhou from 2004 to 2005. Chinese Journal of AIDS & STD 2008; 14: 232-4.
[45]
He HL, Xu FL, Cai WP, et al. Epidemiological analysis of HIV-1 in Guangdong Province. Guangdong Yixue 2012; 33: 3471-4.
[47]
Jia YC. A study of 2011 HIV-1 drug-resistant genetic epidemiology characteristics in Yunnan province Master. Dali University 2014.
[48]
Kong DF, Wang XH, Qin YM. Molecular epidemiological characteristics of 528 HIV-1 infected cases in Shenzhen. China Tropical Medicine 2015; 15: 562-4.
[49]
Li GY, He X, Ye JR, et al. Sequence analysis and subtype analysis of env gene in Beijing human immunodeficiency virus type 1 positive drug users. Chin J Prev Med 2010; 44: 572-3.
[50]
Li JJ, Li HQ, Li JY, et al. Characteristics and distribution of HIV-1 subtypes in Yunnan province. Chinese J AIDS STD 2016; 22: 145-9.
[52]
Li XJ, Xia XS, Wu BL, et al. Molecular epidemiology of HIV-1 transmission among injecting drug users and heterosexuals in kunming. Zhongguo Pifu Xingbingxue Zazhi 2009; 23: 294-5.
[53]
Li Y, Xu HF, Han ZG, et al. Sequence analysis of the C2-V3 region among HIV-1 strains found during 2004-2005 in Guangzhou. S China J Prev Med 2008; 34: 26-9.
[57]
Liu LH, Yang LH, Zhao XR, et al. Subtype distribution of HIV-1 among different people infected. Chin J Publ Health 2009; 25: 1023-4.
[58]
Liu XM. Investigation of drug-resistance transmission and subtypes distribution in newly diagnosed HIV-1 case population in Hetian prefecture of XinJiang. Anhui Journal of Preventive Medicine 2016; 22: 371-4.
[60]
Pan XH, Yao YP, Xia SC, et al. Molecular epidemiological study of HIV infection cases in 2003 -2005 in Zhejiang province. Chinese Journal of AIDS & STD 2007; 13: 308-10.
[63]
Tang L, Xing H, Peng JS, et al. Sequence analysis of the HIV-1-related gene in Wuhan city and distribution of its subtypes. Chinese Journal of Zoonoses 2007; 23: 1071-8.
[64]
Wu J, Wang XQ, Zhou YQ, et al. Molecular epidemiological characteristics of Human Immunodeficiency Virus type 1 in Shanghai, 2007-2013. Chinese Journal of AIDS & STD 2016; 22: 5-9.
[65]
Wu ZL, Gou MX, Guan GY, et al. Molecular epidemiological Study on HIV-1 in Ningxia. Ningxia Med J 2017; 39: 781-861.
[66]
Xing AH, Xing H, Li X, et al. Analysis on subtype of epidemic HIV-1 strains in Shanxi province. Chin J Publ Health 2007; 23: 1044-6.
[67]
Xu YY, Jiang WM, Zhou LM, et al. A molecular epidemioiogical survey of 60 human immunodeficiency viruses-1 infected individuals from Honghe district in Yunnan Province. Chinese J Infect Dis 2008; 26: 367-70.
[68]
Yan J, Wang Y, Li J, et al. Molecular epidemiological investigation on HIV-1 epidemic strain. Chin J Publ Health 2005; 21: 96-7.
[71]
Yao YP. Study on transmission and Phylogenetic relationship of HIV-1 in Zhejiang Master. Zhejiang University 2013.
[75]
Zhao F, Cui ZL, Wang C, et al. Epidemiological survey of HIV-1 in drug users from 2006 to 2008 in Henan Province. Wei Sheng Yen Chiu 2009; 38: 574-5.
[77]
Zheng M, Yu XL, Ni YQ, et al. HIV-1 subtype analysis in new HIV-1 infected injection drug users in Shanghai, 2013. J Diagnostics Concepts & Practice 2015; 14: 560-4.
[78]
Zhong HL, Liang ZW, Cai WP, et al. In Guangdong Drug Resistance of Patients with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in 2011 and 2012. China J Pharm Econom 2015; 7: 72-4.
[79]
Zhou LM. A molecular epidemiological survey of HIV-1 infected persons living in Shanghai Master. Fudan University 2006.
[80]
Shao YM, Zhao QB, Wang B, et al. Sequence analysis of HIV env genes among HIV infected drug injecting users in Dehong epidemic area of Yunnan province, China. Chin J Virol 1994; 4: 291-9.
[82]
Chen J, Guan YJ, Shao YM, et al. Subtype and sequence analysis of the C2-V3 region of gp120 gene among HIV-1 infected IDUs in Longchuan epidemic area of Yunnan province, China. Chin J Microbiol Immunol 1997; 17: 1-6.
[88]
Yan Y, Chen G, Shao Y, et al. Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Fujian province. Chin J Microbiol Immunol 2000; 20: 458-61.
[89]
Liu W, Chen J, Li ZJ, et al. Study on epidemiological distribution of HIV-1 subtype in Guangxi. Guangxi J Prev Med 1999; 3: 4-7.
[97]
Feng FM, Li JY, Bao ZY, et al. Strutural characterization and phylogenetic analysis of HIV-1 genome of a prevalent subtype B′ strain in Central China. Virol Sin 2004; 19: 444-8.
[101]
Cao YZ, Li GH, Wang SY, et al. Current situation, crisis and countermeasures of maternal-infant transmission of HIV-1 in China. Chinese Journal of Infectious Diseases 2002; 20: 56-9.